Business Context and Reporting Period
This Form 6-K filing by Concord Medical Services Holdings Ltd (NYSE: CCM) covers the month of May 2026. The report details corporate governance changes at Concord Healthcare Group Co., Ltd., a subsidiary listed on the Hong Kong Stock Exchange (2453.HK).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
Material changes reported in this filing are limited to the composition of the board of directors at Concord Healthcare Group Co., Ltd., effective May 11, 2026:
- Appointments: Mr. Wei Jiang (current President) was appointed as an executive director, succeeding Ms. Xiao Fu who retired. Ms. Li Jiang (current Investor Relations Manager) was elected as an employee director.
- Resignations: Ms. Xiao Fu resigned due to retirement age. Mr. Liang Chang resigned as an executive director due to personal career planning.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It notes that Concord Healthcare's H shares were previously listed on the HKSE in January 2024 and directs investors to the HKSE website for the subsidiary's annual report.
Investor Verification Checklist
- Verify the impact of the board composition changes on Concord Healthcare's strategic direction.
- Review the full annual report of Concord Healthcare Group Co., Ltd. on the HKSE website for financial data not included in this 6-K.
- Confirm the effective dates of the new directors' terms and any potential transition periods.